Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS).

PubWeight™: 2.11‹?› | Rank: Top 2%

🔗 View Article (PMC 1754067)

Published in Ann Rheum Dis on April 01, 2002

Authors

A Young1, J Dixey, E Kulinskaya, N Cox, P Davies, J Devlin, P Emery, A Gough, D James, P Prouse, P Williams, J Winfield

Author Affiliations

1: Rheumatology Unit, City Hospital, St Albans, Herts AL3 5PN, UK. erascm@hotmail.com

Articles citing this

Predictive factors of work disability in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis (2004) 1.57

Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity. Ann Rheum Dis (2005) 1.21

Long term safety of etanercept in elderly subjects with rheumatic diseases. Ann Rheum Dis (2005) 1.19

Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity. Rheumatology (Oxford) (2009) 1.10

Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol. Rheumatology (Oxford) (2010) 1.00

A systematic review of infliximab in the treatment of early rheumatoid arthritis. Ther Clin Risk Manag (2007) 0.98

Efficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study. Indian J Med Res (2015) 0.95

Using intervention mapping (IM) to develop a self-management programme for employees with a chronic disease in the Netherlands. BMC Public Health (2010) 0.94

A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective. Rheumatol Int (2016) 0.93

Work disability among two cohorts of women with recent-onset rheumatoid arthritis: a survival analysis. Arthritis Rheum (2007) 0.89

Work disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores. Open Rheumatol J (2008) 0.87

Negative and positive illness representations of rheumatoid arthritis: a latent profile analysis. J Behav Med (2013) 0.82

Sick leave as a predictor of job loss in patients with chronic arthritis. Int Arch Occup Environ Health (2006) 0.82

Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts. Semin Arthritis Rheum (2014) 0.82

Low prevalence of work disability in early inflammatory arthritis (EIA) and early rheumatoid arthritis at enrollment into a multi-site registry: results from the catch cohort. Rheumatol Int (2012) 0.81

Work disability and state benefit claims in early rheumatoid arthritis: the ERAN cohort. Rheumatology (Oxford) (2013) 0.81

Exploring lifetime occupational exposure and SLE flare: a patient-focussed pilot study. Lupus Sci Med (2014) 0.80

Impact of morning stiffness on working behaviour and performance in people with rheumatoid arthritis. Rheumatol Int (2014) 0.80

Paid work is associated with improved health-related quality of life in patients with rheumatoid arthritis. Clin Rheumatol (2010) 0.80

Cost-utility analysis of tocilizumab monotherapy in first line versus standard of care for the treatment of rheumatoid arthritis in Greece. Rheumatol Int (2015) 0.78

A mixed methods protocol to investigate medication adherence in patients with rheumatoid arthritis of White British and South Asian origin. BMJ Open (2013) 0.78

The future of rheumatoid arthritis and hand surgery - combining evolutionary pharmacology and surgical technique. Open Orthop J (2012) 0.77

Which patients with rheumatoid arthritis are still working? Arthritis Res Ther (2010) 0.77

Which patients stop working because of RA? Ann Rheum Dis (2002) 0.77

Influence of rheumatoid arthritis-related morning stiffness on productivity at work: results from a survey in 11 European countries. Rheumatol Int (2015) 0.76

The impact of rheumatoid arthritis and biologics on employers and payers. Biotechnol Healthc (2008) 0.75

The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life. Open Access Rheumatol (2009) 0.75

The impact of using musculoskeletal ultrasound imaging and other influencing factors on medication adherence in patients with rheumatoid arthritis: a qualitative study. Patient Prefer Adherence (2016) 0.75

The Short Form Score for the Assessment and Quantification of Chronic Rheumatic Affections of the Hands in Daily Clinical Routines-Its Sensitivity to Change and Preliminary Patient Relevant Variation Values: A Pilot Study. Front Med (Lausanne) (2017) 0.75

Effect of panchakarma and Ayurvedic treatment in postpartum rheumatoid arthritis (amavata): A case study. J Ayurveda Integr Med (2017) 0.75

Protocol for a randomised controlled trial for Reducing Arthritis Fatigue by clinical Teams (RAFT) using cognitive-behavioural approaches. BMJ Open (2015) 0.75

Rheumatoid Arthritis Disease Activity Is Determinant for ABCB1 and ABCG2 Drug-Efflux Transporters Function. PLoS One (2016) 0.75

Work instability in rheumatoid arthritis patients from Argentina: prevalence and associated factors. Rheumatol Int (2014) 0.75

Work disability is related to the presence of arthritis and not to a specific diagnosis. Results from a large early arthritis cohort in Argentina. Clin Rheumatol (2014) 0.75

Articles cited by this

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05

Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med (1968) 27.34

Measurement of patient outcome in arthritis. Arthritis Rheum (1980) 21.31

The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol (1983) 8.37

Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis (1990) 5.49

The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients. J Rheumatol (1998) 2.30

How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS) Rheumatology (Oxford) (2000) 2.21

Work disability in rheumatoid arthritis: effects of disease, social, and work factors. Ann Intern Med (1980) 1.87

The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology (Oxford) (2000) 1.59

Socio-economic consequences of rheumatoid arthritis in the first years of the disease. Rheumatology (Oxford) (1999) 1.44

Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study. Rheumatology (Oxford) (1999) 1.43

Functional impairment and disability in early rheumatoid arthritis--development over 5 years. J Rheumatol (1995) 1.37

Work disability in early rheumatoid arthritis. Ann Rheum Dis (1995) 1.34

Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J Clin Epidemiol (1992) 1.32

Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol (1999) 1.29

Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using RECPAM. Br J Rheumatol (1996) 1.24

Predictors of work disability in rheumatoid arthritis patients. A five-year followup. Arthritis Rheum (1995) 1.23

Effect of rheumatoid arthritis on work status and social and leisure time activities in patients followed 8 years from onset. J Rheumatol (1998) 1.20

Effects of rheumatoid arthritis on employment and social participation during the first years of disease in The Netherlands. Br J Rheumatol (1998) 1.20

Socioeconomic deprivation and rheumatoid disease: what lessons for the health service? ERAS Study Group. Early Rheumatoid Arthritis Study. Ann Rheum Dis (2000) 1.08

Prognosis of functional capacity and work capacity in rheumatoid arthritis. Clin Rheumatol (1982) 1.06

Can we predict aggressive disease? Baillieres Clin Rheumatol (1997) 1.04

Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial. J Rheumatol (1991) 0.96

Rheumatoid arthritis, disability and the workplace. Baillieres Best Pract Res Clin Rheumatol (1999) 0.89

Work capacity of patients with inflammatory joint diseases. An eight-year follow-up study. Scand J Rheumatol (1987) 0.86

The course of rheumatoid arthritis. Baillieres Clin Rheumatol (1992) 0.82

Articles by these authors

The genome sequence of Drosophila melanogaster. Science (2000) 74.32

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science (1998) 19.40

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med (2000) 16.20

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet (1999) 11.92

Direct gene transfer into mouse muscle in vivo. Science (1990) 10.39

Quorum sensing and Chromobacterium violaceum: exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones. Microbiology (1997) 7.83

Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71

Conservation conflicts across Africa. Science (2001) 7.09

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA (2000) 6.55

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet (2000) 6.12

Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet (1976) 6.09

A hierarchical quorum-sensing cascade in Pseudomonas aeruginosa links the transcriptional activators LasR and RhIR (VsmR) to expression of the stationary-phase sigma factor RpoS. Mol Microbiol (1996) 6.07

Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet (1993) 5.70

Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J Virol (1998) 5.48

Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U S A (2000) 5.36

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM (1994) 5.23

Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet (1997) 5.22

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum (2006) 5.20

Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol (1988) 5.18

Multiple homologues of LuxR and LuxI control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1. Mol Microbiol (1995) 5.12

A survey of psychiatrists in primary care: the silent growth of a new service. J R Coll Gen Pract (1984) 5.04

General practitioners and psychiatrists--do they communicate? Br Med J (1974) 4.98

A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) (2003) 4.86

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.83

Role of contractile microfilaments in macrophage movement and endocytosis. Nat New Biol (1971) 4.82

The cryb mutation identifies cryptochrome as a circadian photoreceptor in Drosophila. Cell (1998) 4.81

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78

Macrophages synthesis and release prostaglandins in response to inflammatory stimuli. Nature (1977) 4.75

The bacterial 'enigma': cracking the code of cell-cell communication. Mol Microbiol (1995) 4.66

Effect of prenatal and infancy home visitation by nurses on pregnancy outcomes, childhood injuries, and repeated childbearing. A randomized controlled trial. JAMA (1997) 4.54

Classification of inflammatory arthritis by enthesitis. Lancet (1998) 4.48

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum (1998) 4.37

Construction and analysis of luxCDABE-based plasmid sensors for investigating N-acyl homoserine lactone-mediated quorum sensing. FEMS Microbiol Lett (1998) 4.36

Prediction of survival for preterm births by weight and gestational age: retrospective population based study. BMJ (1999) 4.31

A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A (1990) 4.26

An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum (2008) 4.25

Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ (1999) 4.14

A randomized trial of group outpatient visits for chronically ill older HMO members: the Cooperative Health Care Clinic. J Am Geriatr Soc (1997) 4.09

The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature (1999) 3.96

Generalised bone loss in patients with early rheumatoid arthritis. Lancet (1994) 3.93

The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum (2000) 3.85

A novel regulatory system required for pathogenicity of Xanthomonas campestris is mediated by a small diffusible signal molecule. Mol Microbiol (1997) 3.73

Involvement of N-acyl-L-hormoserine lactone autoinducers in controlling the multicellular behaviour of Serratia liquefaciens. Mol Microbiol (1996) 3.71

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother (2004) 3.69

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Ann Rheum Dis (2004) 3.64

Regional organisation of neonatal intensive care in the North-west. Br Med J (1979) 3.50

A neuronal antigen in the brains of Alzheimer patients. Science (1986) 3.49

N-(3-oxohexanoyl)-L-homoserine lactone regulates carbapenem antibiotic production in Erwinia carotovora. Biochem J (1992) 3.40

Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia (2009) 3.40

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32

Changing patterns of psychiatric care. Br Med J (Clin Res Ed) (1981) 3.27

Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology (1987) 3.24

The influence of environment on envelope properties affecting survival of bacteria in infections. Annu Rev Microbiol (1985) 3.24

A comparison of the validity of two psychiatric screening questionnaires (GHQ-12 and SRQ-20) in Brazil, using Relative Operating Characteristic (ROC) analysis. Psychol Med (1985) 3.20

Screening for psychiatric disorder in general practice. Psychol Med (1984) 3.18

The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone has immunomodulatory activity. Infect Immun (1998) 3.16

Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology (1999) 3.16

Health of long term benzodiazepine users. Br Med J (Clin Res Ed) (1988) 3.12

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ (2000) 3.10

Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging (1992) 3.05

Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum (2006) 3.03

Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00

The development of a computerized assessment for minor psychiatric disorder. Psychol Med (1988) 2.95

Quorum sensing: a population-density component in the determination of bacterial phenotype. Trends Biochem Sci (1996) 2.87

Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes. Nature (1974) 2.86

Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet (1984) 2.83

Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet (1988) 2.80

Regulation of prostaglandin synthesis and of the selective release of lysosomal hydrolases by mouse peritoneal macrophages. Biochem J (1978) 2.77

The global posttranscriptional regulator RsmA modulates production of virulence determinants and N-acylhomoserine lactones in Pseudomonas aeruginosa. J Bacteriol (2001) 2.76

Quorum sensing in Aeromonas hydrophila and Aeromonas salmonicida: identification of the LuxRI homologs AhyRI and AsaRI and their cognate N-acylhomoserine lactone signal molecules. J Bacteriol (1997) 2.76

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis (2011) 2.74

No more infected sockets? Br Dent J (2006) 2.74

Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum (1994) 2.74

Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity (1998) 2.73

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet (1992) 2.72

Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance. J Exp Med (1974) 2.72

Rising prevalence of human T-lymphotropic virus type III (HTLV-III) infection in homosexual men in London. Lancet (1985) 2.72

Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res (1997) 2.71

Intelligence and the frontal lobe: the organization of goal-directed behavior. Cogn Psychol (1996) 2.69

Physiological factors associated with falls in older community-dwelling women. J Am Geriatr Soc (1994) 2.69

HLA and mate choice in humans. Am J Hum Genet (1997) 2.66

Engineering the luxCDABE genes from Photorhabdus luminescens to provide a bioluminescent reporter for constitutive and promoter probe plasmids and mini-Tn5 constructs. FEMS Microbiol Lett (1998) 2.65

An epidemiological study of falls in older community-dwelling women: the Randwick falls and fractures study. Aust J Public Health (1993) 2.59

Quorum-sensing cross talk: isolation and chemical characterization of cyclic dipeptides from Pseudomonas aeruginosa and other gram-negative bacteria. Mol Microbiol (1999) 2.59

Chlamydia trachomatis and reactive arthritis: the missing link. Lancet (1987) 2.59

Current status of zirconia used in total hip implants. J Bone Joint Surg Am (2003) 2.56

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55

Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford) (2006) 2.54

Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann Neurol (1994) 2.54

Autoregulation of carbapenem biosynthesis in Erwinia carotovora by analogues of N-(3-oxohexanoyl)-L-homoserine lactone. J Antibiot (Tokyo) (1993) 2.53

The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence? Rheumatology (Oxford) (2001) 2.52

Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum (1998) 2.51

Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study. Arthritis Rheum (2001) 2.49

Failure to deliver hepatitis B vaccine: confessions from a genitourinary medicine clinic. BMJ (1991) 2.49

EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis (2004) 2.48

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann Rheum Dis (2008) 2.45